Digital health company Noom has launched a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide to make the drug more accessible to consumers in the US. In this issue ...

Noom Appoints Olcott to Advance Noom Med Programming Following Newly Launched GLP-1 Rx Solution NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed ...

Noom stands behind its program with a “Taper-Off Guarantee” offering a pathway off supposedly forever medications. Solves the biggest real-world challenges with GLP-1s – poor persistence and ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more accessible to consumers. The company, which developed an app that helps people ...

NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, is pleased to announce ...

Noom said that it plans to offer a compounded formulation of Novo Nordisk’s (NVO) popular GLP-1 drug semaglutide at discount prices as part of a new weight-loss program called Noom GLP-1 Rx that ...

Noom wanted to change the way people created healthy lifestyle habits by reinventing how health-based apps worked when it was founded in New York in 2016. Instead of using the semi-toxic ideology ...

Digital health company Noom has launched a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide to make the drug more accessible to consumers in the US. The bold move has been ...

The SpaceNews Commercial Space Transformer video series will give viewers a behind-the-scenes look at the people and companies driving the space industry’s commercial transformation. The weekly ...

Forbes Health editors consulted with a panel of nutrition and weight loss experts for their top commercial weight loss program recommendations. The top two programs on our list received two ...